 | • レポートコード：MRC308GR11531 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のプロスタサイクリン受容体作動薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のプロスタサイクリン受容体作動薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– プロスタサイクリン受容体作動薬の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
プロスタサイクリン受容体作動薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・エポプロステノールナトリウム、トレプロスチニル、ベラプロスト
用途別セグメント
・病院、製薬会社、研究所、診療所、その他
主要な市場プレーヤー
・United Therapeutics Corporation、Pfizer、Insmed Incorporated、Gilead Sciences、CRISPR Therapeutics、Chiesi Farmaceutici、Bayer AG、Arena Pharmaceuticals、Actelion Pharmaceuticals
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、プロスタサイクリン受容体作動薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なプロスタサイクリン受容体作動薬メーカーの企業概要、2019年～2022年までのプロスタサイクリン受容体作動薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なプロスタサイクリン受容体作動薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別プロスタサイクリン受容体作動薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのプロスタサイクリン受容体作動薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのプロスタサイクリン受容体作動薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびプロスタサイクリン受容体作動薬の産業チェーンを掲載しています。
・第14、15章では、プロスタサイクリン受容体作動薬の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– プロスタサイクリン受容体作動薬の概要
– 種類別分析（2018年vs2022年vs2029年）：エポプロステノールナトリウム、トレプロスチニル、ベラプロスト
– 用途別分析（2018年vs2022年vs2029年）：病院、製薬会社、研究所、診療所、その他
– 世界のプロスタサイクリン受容体作動薬市場規模・予測
– 世界のプロスタサイクリン受容体作動薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– United Therapeutics Corporation、Pfizer、Insmed Incorporated、Gilead Sciences、CRISPR Therapeutics、Chiesi Farmaceutici、Bayer AG、Arena Pharmaceuticals、Actelion Pharmaceuticals
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：エポプロステノールナトリウム、トレプロスチニル、ベラプロスト
・用途別分析2018年-2029年：病院、製薬会社、研究所、診療所、その他
・プロスタサイクリン受容体作動薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・プロスタサイクリン受容体作動薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・プロスタサイクリン受容体作動薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・プロスタサイクリン受容体作動薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・プロスタサイクリン受容体作動薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Prostacyclin Receptor Agonist
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Prostacyclin Receptor Agonist Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Epoprostenol Sodium
1.3.3 Treprostinil
1.3.4 Beraprost
1.4 Market Analysis by Application
1.4.1 Overview: Global Prostacyclin Receptor Agonist Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Pharmaceutical Company
1.4.4 Laboratory
1.4.5 Clinic
1.4.6 Others
1.5 Global Prostacyclin Receptor Agonist Market Size & Forecast
1.5.1 Global Prostacyclin Receptor Agonist Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Prostacyclin Receptor Agonist Sales Quantity (2018-2029)
1.5.3 Global Prostacyclin Receptor Agonist Average Price (2018-2029)
2 Manufacturers Profiles
2.1 United Therapeutics Corporation
2.1.1 United Therapeutics Corporation Details
2.1.2 United Therapeutics Corporation Major Business
2.1.3 United Therapeutics Corporation Prostacyclin Receptor Agonist Product and Services
2.1.4 United Therapeutics Corporation Prostacyclin Receptor Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 United Therapeutics Corporation Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Prostacyclin Receptor Agonist Product and Services
2.2.4 Pfizer Prostacyclin Receptor Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer Recent Developments/Updates
2.3 Insmed Incorporated
2.3.1 Insmed Incorporated Details
2.3.2 Insmed Incorporated Major Business
2.3.3 Insmed Incorporated Prostacyclin Receptor Agonist Product and Services
2.3.4 Insmed Incorporated Prostacyclin Receptor Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Insmed Incorporated Recent Developments/Updates
2.4 Gilead Sciences
2.4.1 Gilead Sciences Details
2.4.2 Gilead Sciences Major Business
2.4.3 Gilead Sciences Prostacyclin Receptor Agonist Product and Services
2.4.4 Gilead Sciences Prostacyclin Receptor Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Gilead Sciences Recent Developments/Updates
2.5 CRISPR Therapeutics
2.5.1 CRISPR Therapeutics Details
2.5.2 CRISPR Therapeutics Major Business
2.5.3 CRISPR Therapeutics Prostacyclin Receptor Agonist Product and Services
2.5.4 CRISPR Therapeutics Prostacyclin Receptor Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 CRISPR Therapeutics Recent Developments/Updates
2.6 Chiesi Farmaceutici
2.6.1 Chiesi Farmaceutici Details
2.6.2 Chiesi Farmaceutici Major Business
2.6.3 Chiesi Farmaceutici Prostacyclin Receptor Agonist Product and Services
2.6.4 Chiesi Farmaceutici Prostacyclin Receptor Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Chiesi Farmaceutici Recent Developments/Updates
2.7 Bayer AG
2.7.1 Bayer AG Details
2.7.2 Bayer AG Major Business
2.7.3 Bayer AG Prostacyclin Receptor Agonist Product and Services
2.7.4 Bayer AG Prostacyclin Receptor Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bayer AG Recent Developments/Updates
2.8 Arena Pharmaceuticals
2.8.1 Arena Pharmaceuticals Details
2.8.2 Arena Pharmaceuticals Major Business
2.8.3 Arena Pharmaceuticals Prostacyclin Receptor Agonist Product and Services
2.8.4 Arena Pharmaceuticals Prostacyclin Receptor Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Arena Pharmaceuticals Recent Developments/Updates
2.9 Actelion Pharmaceuticals
2.9.1 Actelion Pharmaceuticals Details
2.9.2 Actelion Pharmaceuticals Major Business
2.9.3 Actelion Pharmaceuticals Prostacyclin Receptor Agonist Product and Services
2.9.4 Actelion Pharmaceuticals Prostacyclin Receptor Agonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Actelion Pharmaceuticals Recent Developments/Updates
3 Competitive Environment: Prostacyclin Receptor Agonist by Manufacturer
3.1 Global Prostacyclin Receptor Agonist Sales Quantity by Manufacturer (2018-2023)
3.2 Global Prostacyclin Receptor Agonist Revenue by Manufacturer (2018-2023)
3.3 Global Prostacyclin Receptor Agonist Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Prostacyclin Receptor Agonist by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Prostacyclin Receptor Agonist Manufacturer Market Share in 2022
3.4.2 Top 6 Prostacyclin Receptor Agonist Manufacturer Market Share in 2022
3.5 Prostacyclin Receptor Agonist Market: Overall Company Footprint Analysis
3.5.1 Prostacyclin Receptor Agonist Market: Region Footprint
3.5.2 Prostacyclin Receptor Agonist Market: Company Product Type Footprint
3.5.3 Prostacyclin Receptor Agonist Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Prostacyclin Receptor Agonist Market Size by Region
4.1.1 Global Prostacyclin Receptor Agonist Sales Quantity by Region (2018-2029)
4.1.2 Global Prostacyclin Receptor Agonist Consumption Value by Region (2018-2029)
4.1.3 Global Prostacyclin Receptor Agonist Average Price by Region (2018-2029)
4.2 North America Prostacyclin Receptor Agonist Consumption Value (2018-2029)
4.3 Europe Prostacyclin Receptor Agonist Consumption Value (2018-2029)
4.4 Asia-Pacific Prostacyclin Receptor Agonist Consumption Value (2018-2029)
4.5 South America Prostacyclin Receptor Agonist Consumption Value (2018-2029)
4.6 Middle East and Africa Prostacyclin Receptor Agonist Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Prostacyclin Receptor Agonist Sales Quantity by Type (2018-2029)
5.2 Global Prostacyclin Receptor Agonist Consumption Value by Type (2018-2029)
5.3 Global Prostacyclin Receptor Agonist Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Prostacyclin Receptor Agonist Sales Quantity by Application (2018-2029)
6.2 Global Prostacyclin Receptor Agonist Consumption Value by Application (2018-2029)
6.3 Global Prostacyclin Receptor Agonist Average Price by Application (2018-2029)
7 North America
7.1 North America Prostacyclin Receptor Agonist Sales Quantity by Type (2018-2029)
7.2 North America Prostacyclin Receptor Agonist Sales Quantity by Application (2018-2029)
7.3 North America Prostacyclin Receptor Agonist Market Size by Country
7.3.1 North America Prostacyclin Receptor Agonist Sales Quantity by Country (2018-2029)
7.3.2 North America Prostacyclin Receptor Agonist Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Prostacyclin Receptor Agonist Sales Quantity by Type (2018-2029)
8.2 Europe Prostacyclin Receptor Agonist Sales Quantity by Application (2018-2029)
8.3 Europe Prostacyclin Receptor Agonist Market Size by Country
8.3.1 Europe Prostacyclin Receptor Agonist Sales Quantity by Country (2018-2029)
8.3.2 Europe Prostacyclin Receptor Agonist Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Prostacyclin Receptor Agonist Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Prostacyclin Receptor Agonist Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Prostacyclin Receptor Agonist Market Size by Region
9.3.1 Asia-Pacific Prostacyclin Receptor Agonist Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Prostacyclin Receptor Agonist Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Prostacyclin Receptor Agonist Sales Quantity by Type (2018-2029)
10.2 South America Prostacyclin Receptor Agonist Sales Quantity by Application (2018-2029)
10.3 South America Prostacyclin Receptor Agonist Market Size by Country
10.3.1 South America Prostacyclin Receptor Agonist Sales Quantity by Country (2018-2029)
10.3.2 South America Prostacyclin Receptor Agonist Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Prostacyclin Receptor Agonist Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Prostacyclin Receptor Agonist Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Prostacyclin Receptor Agonist Market Size by Country
11.3.1 Middle East & Africa Prostacyclin Receptor Agonist Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Prostacyclin Receptor Agonist Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Prostacyclin Receptor Agonist Market Drivers
12.2 Prostacyclin Receptor Agonist Market Restraints
12.3 Prostacyclin Receptor Agonist Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Prostacyclin Receptor Agonist and Key Manufacturers
13.2 Manufacturing Costs Percentage of Prostacyclin Receptor Agonist
13.3 Prostacyclin Receptor Agonist Production Process
13.4 Prostacyclin Receptor Agonist Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Prostacyclin Receptor Agonist Typical Distributors
14.3 Prostacyclin Receptor Agonist Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Prostacyclin Receptor Agonist Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Prostacyclin Receptor Agonist Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. United Therapeutics Corporation Basic Information, Manufacturing Base and Competitors
Table 4. United Therapeutics Corporation Major Business
Table 5. United Therapeutics Corporation Prostacyclin Receptor Agonist Product and Services
Table 6. United Therapeutics Corporation Prostacyclin Receptor Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. United Therapeutics Corporation Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Prostacyclin Receptor Agonist Product and Services
Table 11. Pfizer Prostacyclin Receptor Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Pfizer Recent Developments/Updates
Table 13. Insmed Incorporated Basic Information, Manufacturing Base and Competitors
Table 14. Insmed Incorporated Major Business
Table 15. Insmed Incorporated Prostacyclin Receptor Agonist Product and Services
Table 16. Insmed Incorporated Prostacyclin Receptor Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Insmed Incorporated Recent Developments/Updates
Table 18. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 19. Gilead Sciences Major Business
Table 20. Gilead Sciences Prostacyclin Receptor Agonist Product and Services
Table 21. Gilead Sciences Prostacyclin Receptor Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Gilead Sciences Recent Developments/Updates
Table 23. CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. CRISPR Therapeutics Major Business
Table 25. CRISPR Therapeutics Prostacyclin Receptor Agonist Product and Services
Table 26. CRISPR Therapeutics Prostacyclin Receptor Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. CRISPR Therapeutics Recent Developments/Updates
Table 28. Chiesi Farmaceutici Basic Information, Manufacturing Base and Competitors
Table 29. Chiesi Farmaceutici Major Business
Table 30. Chiesi Farmaceutici Prostacyclin Receptor Agonist Product and Services
Table 31. Chiesi Farmaceutici Prostacyclin Receptor Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Chiesi Farmaceutici Recent Developments/Updates
Table 33. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 34. Bayer AG Major Business
Table 35. Bayer AG Prostacyclin Receptor Agonist Product and Services
Table 36. Bayer AG Prostacyclin Receptor Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Bayer AG Recent Developments/Updates
Table 38. Arena Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. Arena Pharmaceuticals Major Business
Table 40. Arena Pharmaceuticals Prostacyclin Receptor Agonist Product and Services
Table 41. Arena Pharmaceuticals Prostacyclin Receptor Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Arena Pharmaceuticals Recent Developments/Updates
Table 43. Actelion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Actelion Pharmaceuticals Major Business
Table 45. Actelion Pharmaceuticals Prostacyclin Receptor Agonist Product and Services
Table 46. Actelion Pharmaceuticals Prostacyclin Receptor Agonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Actelion Pharmaceuticals Recent Developments/Updates
Table 48. Global Prostacyclin Receptor Agonist Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 49. Global Prostacyclin Receptor Agonist Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Prostacyclin Receptor Agonist Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 51. Market Position of Manufacturers in Prostacyclin Receptor Agonist, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Prostacyclin Receptor Agonist Production Site of Key Manufacturer
Table 53. Prostacyclin Receptor Agonist Market: Company Product Type Footprint
Table 54. Prostacyclin Receptor Agonist Market: Company Product Application Footprint
Table 55. Prostacyclin Receptor Agonist New Market Entrants and Barriers to Market Entry
Table 56. Prostacyclin Receptor Agonist Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Prostacyclin Receptor Agonist Sales Quantity by Region (2018-2023) & (K Units)
Table 58. Global Prostacyclin Receptor Agonist Sales Quantity by Region (2024-2029) & (K Units)
Table 59. Global Prostacyclin Receptor Agonist Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Prostacyclin Receptor Agonist Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Prostacyclin Receptor Agonist Average Price by Region (2018-2023) & (US$/Unit)
Table 62. Global Prostacyclin Receptor Agonist Average Price by Region (2024-2029) & (US$/Unit)
Table 63. Global Prostacyclin Receptor Agonist Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Global Prostacyclin Receptor Agonist Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Global Prostacyclin Receptor Agonist Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Prostacyclin Receptor Agonist Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Prostacyclin Receptor Agonist Average Price by Type (2018-2023) & (US$/Unit)
Table 68. Global Prostacyclin Receptor Agonist Average Price by Type (2024-2029) & (US$/Unit)
Table 69. Global Prostacyclin Receptor Agonist Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Global Prostacyclin Receptor Agonist Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Global Prostacyclin Receptor Agonist Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Prostacyclin Receptor Agonist Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Prostacyclin Receptor Agonist Average Price by Application (2018-2023) & (US$/Unit)
Table 74. Global Prostacyclin Receptor Agonist Average Price by Application (2024-2029) & (US$/Unit)
Table 75. North America Prostacyclin Receptor Agonist Sales Quantity by Type (2018-2023) & (K Units)
Table 76. North America Prostacyclin Receptor Agonist Sales Quantity by Type (2024-2029) & (K Units)
Table 77. North America Prostacyclin Receptor Agonist Sales Quantity by Application (2018-2023) & (K Units)
Table 78. North America Prostacyclin Receptor Agonist Sales Quantity by Application (2024-2029) & (K Units)
Table 79. North America Prostacyclin Receptor Agonist Sales Quantity by Country (2018-2023) & (K Units)
Table 80. North America Prostacyclin Receptor Agonist Sales Quantity by Country (2024-2029) & (K Units)
Table 81. North America Prostacyclin Receptor Agonist Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Prostacyclin Receptor Agonist Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Prostacyclin Receptor Agonist Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Europe Prostacyclin Receptor Agonist Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Europe Prostacyclin Receptor Agonist Sales Quantity by Application (2018-2023) & (K Units)
Table 86. Europe Prostacyclin Receptor Agonist Sales Quantity by Application (2024-2029) & (K Units)
Table 87. Europe Prostacyclin Receptor Agonist Sales Quantity by Country (2018-2023) & (K Units)
Table 88. Europe Prostacyclin Receptor Agonist Sales Quantity by Country (2024-2029) & (K Units)
Table 89. Europe Prostacyclin Receptor Agonist Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Prostacyclin Receptor Agonist Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Prostacyclin Receptor Agonist Sales Quantity by Type (2018-2023) & (K Units)
Table 92. Asia-Pacific Prostacyclin Receptor Agonist Sales Quantity by Type (2024-2029) & (K Units)
Table 93. Asia-Pacific Prostacyclin Receptor Agonist Sales Quantity by Application (2018-2023) & (K Units)
Table 94. Asia-Pacific Prostacyclin Receptor Agonist Sales Quantity by Application (2024-2029) & (K Units)
Table 95. Asia-Pacific Prostacyclin Receptor Agonist Sales Quantity by Region (2018-2023) & (K Units)
Table 96. Asia-Pacific Prostacyclin Receptor Agonist Sales Quantity by Region (2024-2029) & (K Units)
Table 97. Asia-Pacific Prostacyclin Receptor Agonist Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Prostacyclin Receptor Agonist Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Prostacyclin Receptor Agonist Sales Quantity by Type (2018-2023) & (K Units)
Table 100. South America Prostacyclin Receptor Agonist Sales Quantity by Type (2024-2029) & (K Units)
Table 101. South America Prostacyclin Receptor Agonist Sales Quantity by Application (2018-2023) & (K Units)
Table 102. South America Prostacyclin Receptor Agonist Sales Quantity by Application (2024-2029) & (K Units)
Table 103. South America Prostacyclin Receptor Agonist Sales Quantity by Country (2018-2023) & (K Units)
Table 104. South America Prostacyclin Receptor Agonist Sales Quantity by Country (2024-2029) & (K Units)
Table 105. South America Prostacyclin Receptor Agonist Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Prostacyclin Receptor Agonist Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Prostacyclin Receptor Agonist Sales Quantity by Type (2018-2023) & (K Units)
Table 108. Middle East & Africa Prostacyclin Receptor Agonist Sales Quantity by Type (2024-2029) & (K Units)
Table 109. Middle East & Africa Prostacyclin Receptor Agonist Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East & Africa Prostacyclin Receptor Agonist Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Middle East & Africa Prostacyclin Receptor Agonist Sales Quantity by Region (2018-2023) & (K Units)
Table 112. Middle East & Africa Prostacyclin Receptor Agonist Sales Quantity by Region (2024-2029) & (K Units)
Table 113. Middle East & Africa Prostacyclin Receptor Agonist Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Prostacyclin Receptor Agonist Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Prostacyclin Receptor Agonist Raw Material
Table 116. Key Manufacturers of Prostacyclin Receptor Agonist Raw Materials
Table 117. Prostacyclin Receptor Agonist Typical Distributors
Table 118. Prostacyclin Receptor Agonist Typical Customers
List of Figures
Figure 1. Prostacyclin Receptor Agonist Picture
Figure 2. Global Prostacyclin Receptor Agonist Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Prostacyclin Receptor Agonist Consumption Value Market Share by Type in 2022
Figure 4. Epoprostenol Sodium Examples
Figure 5. Treprostinil Examples
Figure 6. Beraprost Examples
Figure 7. Global Prostacyclin Receptor Agonist Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Prostacyclin Receptor Agonist Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Pharmaceutical Company Examples
Figure 11. Laboratory Examples
Figure 12. Clinic Examples
Figure 13. Others Examples
Figure 14. Global Prostacyclin Receptor Agonist Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Prostacyclin Receptor Agonist Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Prostacyclin Receptor Agonist Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Prostacyclin Receptor Agonist Average Price (2018-2029) & (US$/Unit)
Figure 18. Global Prostacyclin Receptor Agonist Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Prostacyclin Receptor Agonist Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Prostacyclin Receptor Agonist by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Prostacyclin Receptor Agonist Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Prostacyclin Receptor Agonist Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Prostacyclin Receptor Agonist Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Prostacyclin Receptor Agonist Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Prostacyclin Receptor Agonist Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Prostacyclin Receptor Agonist Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Prostacyclin Receptor Agonist Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Prostacyclin Receptor Agonist Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Prostacyclin Receptor Agonist Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Prostacyclin Receptor Agonist Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Prostacyclin Receptor Agonist Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Prostacyclin Receptor Agonist Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global Prostacyclin Receptor Agonist Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Prostacyclin Receptor Agonist Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Prostacyclin Receptor Agonist Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America Prostacyclin Receptor Agonist Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Prostacyclin Receptor Agonist Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Prostacyclin Receptor Agonist Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Prostacyclin Receptor Agonist Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Prostacyclin Receptor Agonist Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Prostacyclin Receptor Agonist Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Prostacyclin Receptor Agonist Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Prostacyclin Receptor Agonist Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Prostacyclin Receptor Agonist Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Prostacyclin Receptor Agonist Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Prostacyclin Receptor Agonist Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Prostacyclin Receptor Agonist Consumption Value Market Share by Region (2018-2029)
Figure 56. China Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Prostacyclin Receptor Agonist Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Prostacyclin Receptor Agonist Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Prostacyclin Receptor Agonist Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Prostacyclin Receptor Agonist Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Prostacyclin Receptor Agonist Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Prostacyclin Receptor Agonist Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Prostacyclin Receptor Agonist Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Prostacyclin Receptor Agonist Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Prostacyclin Receptor Agonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Prostacyclin Receptor Agonist Market Drivers
Figure 77. Prostacyclin Receptor Agonist Market Restraints
Figure 78. Prostacyclin Receptor Agonist Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Prostacyclin Receptor Agonist in 2022
Figure 81. Manufacturing Process Analysis of Prostacyclin Receptor Agonist
Figure 82. Prostacyclin Receptor Agonist Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
